|Horizon||30 Days Login to change|
XTL Biopharmaceutica Market Sensitivity
XTL Biopharmaceuticals Technical Analysis
XTL Biopharmaceutica Projected Return Density Against MarketAssuming 30 trading days horizon, XTL Biopharmaceutica has beta of 0.288 . This means as returns on market go up, XTL Biopharmaceutica average returns are expected to increase less than the benchmark. However during bear market, the loss on holding XTL Biopharmaceuticals Ltd will be expected to be much smaller as well. Moreover, XTL Biopharmaceuticals Ltd has an alpha of 0.9644 implying that it can potentially generate 0.9644% excess return over DOW after adjusting for the inherited market risk (beta).
XTL Biopharmaceutica Return VolatilityXTL Biopharmaceuticals Ltd accepts 9.1176% volatility on return distribution over the 30 days horizon. DOW inherits 1.3055% risk (volatility on return distribution) over the 30 days horizon.